Literature DB >> 22533778

Intra-individual variability across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with serostatus and unemployment risk.

Erin E Morgan1, Steven Paul Woods, Alexandra Rooney, William Perry, Igor Grant, Scott L Letendre.   

Abstract

Approximately one-third of persons infected with the hepatitis C virus (HCV) evidence mild cognitive impairment that is consistent with frontostriatal systems dysfunction, including cognitive dyscontrol, and impacts everyday functioning. The present study examined the effects of HCV on neurocognitive dispersion, or within-person variability in neurocognitive performance across domains, which may be a function of poor sustained cognitive control. High dispersion was also hypothesized to increase risk for unemployment. The study sample included 37 individuals with HCV infection (HCV+) and 45 demographically comparable uninfected comparison participants (HCV-). Dispersion was operationalized as an intra-individual standard deviation (ISD) calculated across the demographically adjusted T-scores of 13 standard neuropsychological tests. Multiple linear regression and logistic regression approaches were used to evaluate associations between dispersion and HCV serostatus and employment status, respectively. HCV serostatus was significantly associated with higher dispersion, independent of mean level of neurocognitive ability, psychiatric factors, and liver disease severity. Within the HCV+ group, higher dispersion was associated with an increased risk of unemployment among individuals with higher overall mean neurocognitive ability. Increased neurocognitive dispersion among HCV+ individuals may indicate vulnerability to cognitive dyscontrol expressed as poor regulation of performance across tasks. Higher dispersion may manifest as functional difficulties in daily life, particularly among neurocognitively normal HCV-infected persons, which speaks to the potential clinical value of considering intra-individual variability when evaluating risk for everyday function problems in this population.

Entities:  

Mesh:

Year:  2012        PMID: 22533778      PMCID: PMC3412152          DOI: 10.1080/13854046.2012.680912

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  50 in total

Review 1.  Applications of magnetic resonance spectroscopy to chronic liver disease.

Authors:  S D Taylor-Robinson
Journal:  Clin Med (Lond)       Date:  2001 Jan-Feb       Impact factor: 2.659

2.  Lapses of intention and performance variability reveal age-related increases in fluctuations of executive control.

Authors:  Robert West; Kelly J Murphy; Maria L Armilio; Fergus I M Craik; Donald T Stuss
Journal:  Brain Cogn       Date:  2002-08       Impact factor: 2.310

3.  Neuropsychological impairment in patients with chronic hepatitis C.

Authors:  Robin C Hilsabeck; William Perry; Tarek I Hassanein
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

4.  Variability in reaction time performance of younger and older adults.

Authors:  David F Hultsch; Stuart W S MacDonald; Roger A Dixon
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2002-03       Impact factor: 4.077

5.  Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version.

Authors:  Marc A Norman; David J Moore; Michael Taylor; Donald Franklin; Lucette Cysique; Chris Ake; Deborah Lazarretto; Florin Vaida; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2011-06-24       Impact factor: 2.475

6.  Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid.

Authors:  Tomasz Laskus; Marek Radkowski; Agnieszka Bednarska; Jeffrey Wilkinson; Debra Adair; Marek Nowicki; Georgia B Nikolopoulou; Hugo Vargas; Jorge Rakela
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Staying on the job: the frontal lobes control individual performance variability.

Authors:  Donald T Stuss; Kelly J Murphy; Malcolm A Binns; Michael P Alexander
Journal:  Brain       Date:  2003-07-22       Impact factor: 13.501

8.  Quality of life and cognitive function in hepatitis C at different stages of liver disease.

Authors:  Juan Córdoba; Montse Flavià; Carlos Jacas; Silvia Sauleda; Juan Ignacio Esteban; Víctor Vargas; Rafael Esteban; Jaume Guardia
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

9.  Labour force participation among individuals with hepatitis C in the US.

Authors:  Philip Jacobs; Ying Chu Ng; Tania Stafinski; Roger Dodd; Bryce Larke; Winnie Wong
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 10.  Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

Authors:  Leonard B Seeff; Jay H Hoofnagle
Journal:  Clin Liver Dis       Date:  2003-02       Impact factor: 6.126

View more
  6 in total

1.  Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C.

Authors:  Maiko Sakamoto; Steven Paul Woods; Michael Kolessar; Daniel Kriz; J Renee Anderson; Hannah Olavarria; Anna W Sasaki; Michael Chang; Kenneth D Flora; Jennifer M Loftis; Marilyn Huckans
Journal:  J Neurovirol       Date:  2013-09-10       Impact factor: 2.643

2.  Heterogeneous ability profiles may be a unique indicator of impending cognitive decline.

Authors:  Timothy A Salthouse; Andrea Soubelet
Journal:  Neuropsychology       Date:  2014-05-05       Impact factor: 3.295

3.  Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.

Authors:  Qing Ma; Florin Vaida; Jenna Wong; Chelsea A Sanders; Yu-ting Kao; David Croteau; David B Clifford; Ann C Collier; Benjamin B Gelman; Christina M Marra; Justin C McArthur; Susan Morgello; David M Simpson; Robert K Heaton; Igor Grant; Scott L Letendre
Journal:  J Neurovirol       Date:  2015-09-25       Impact factor: 2.643

4.  Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden.

Authors:  Mandi Musso; Holly James Westervelt; Jeffrey D Long; Erin Morgan; Steven Paul Woods; Megan M Smith; Wenjing Lu; Jane S Paulsen
Journal:  J Int Neuropsychol Soc       Date:  2015-01       Impact factor: 2.892

5.  Does intra-individual neurocognitive variability relate to neuroinvasive disease and quality of life in West Nile Virus?

Authors:  David P Sheppard; Steven Paul Woods; Rodrigo Hasbun; Lucrecia Salazar; Melissa S Nolan; Kristy O Murray
Journal:  J Neurovirol       Date:  2018-04-25       Impact factor: 2.643

6.  Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspective.

Authors:  David J Williamson; Keith H Nuechterlein; Todd Tishler; Joseph Ventura; Benjamin M Ellingson; Ibrahim Turkoz; Richard S E Keefe; Larry Alphs
Journal:  Schizophr Res Cogn       Date:  2022-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.